{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:40:49Z","timestamp":1792730449192,"version":"4.5.0"},"reference-count":211,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T00:00:00Z","timestamp":1400544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T00:00:00Z","timestamp":1400544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1038\/nrneurol.2014.79","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T07:54:20Z","timestamp":1400572460000},"page":"349-362","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Ophthalmic manifestations of inherited neurodegenerative disorders"],"prefix":"10.1038","volume":"10","author":[{"given":"Hannah M.","family":"Kersten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Roxburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen V.","family":"Danesh-Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,20]]},"reference":[{"key":"BFnrneurol201479_CR1","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1093\/brain\/awl174","volume":"129","author":"KW Chung","year":"2006","unstructured":"Chung, K. W. et al. Early onset severe and late-onset mild Charcot\u2013Marie\u2013Tooth disease with mitofusin 2 (MFN2) mutations. Brain 129, 2103\u20132118 (2006).","journal-title":"Brain"},{"key":"BFnrneurol201479_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/brain\/awn269","volume":"132","author":"F Fortuna","year":"2009","unstructured":"Fortuna, F. et al. Visual system involvement in patients with Friedreich's ataxia. Brain 132, 116\u2013123 (2009).","journal-title":"Brain"},{"key":"BFnrneurol201479_CR3","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1093\/brain\/aws240","volume":"135","author":"S Klebe","year":"2012","unstructured":"Klebe, S. et al. Spastic paraplegia gene 7 in patients with spasticity and\/or optic neuropathy. Brain 135, 2980\u20132993 (2012).","journal-title":"Brain"},{"key":"BFnrneurol201479_CR4","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/ICU.0b013e32833eaf71","volume":"21","author":"JH Pula","year":"2010","unstructured":"Pula, J. H., Gomez, C. M. & Kattah, J. C. Ophthalmologic features of the common spinocerebellar ataxias. Curr. Opin. Ophthalmol. 21, 447\u2013453 (2010).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"BFnrneurol201479_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jocn.2009.08.019","volume":"17","author":"BT Grainger","year":"2010","unstructured":"Grainger, B. T., Papchenko, T. L. & Danesh-Meyer, H. V. Optic nerve atrophy in adrenoleukodystrophy detectable by optic coherence tomography. J. Clin. Neurosci. 17, 122\u2013124 (2010).","journal-title":"J. Clin. Neurosci."},{"key":"BFnrneurol201479_CR6","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/eye.2009.336","volume":"24","author":"T Diago","year":"2010","unstructured":"Diago, T., Valls, B. & Pulido, J. S. Coats' disease associated with muscular dystrophy treated with ranibizumab. Eye (Lond.) 24, 1295\u20131296 (2010).","journal-title":"Eye (Lond.)"},{"key":"BFnrneurol201479_CR7","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.ophtha.2010.07.024","volume":"118","author":"B Puech","year":"2011","unstructured":"Puech, B. et al. Kjellin syndrome: long-term neuro-ophthalmologic follow-up and novel mutations in the SPG11 gene. Ophthalmology 118, 564\u2013573 (2011).","journal-title":"Ophthalmology"},{"key":"BFnrneurol201479_CR8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/brain\/110.3.631","volume":"110","author":"RB Fitzsimons","year":"1987","unstructured":"Fitzsimons, R. B., Gurwin, E. B. & Bird, A. C. Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications. Brain 110, 631\u2013648 (1987).","journal-title":"Brain"},{"key":"BFnrneurol201479_CR9","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1006\/exer.2002.1169","volume":"74","author":"TS Aleman","year":"2002","unstructured":"Aleman, T. S. et al. Spinocerebellar ataxia type 7 (SCA7) shows a cone\u2013rod dystrophy phenotype. Exp. Eye Res. 74, 737\u2013745 (2002).","journal-title":"Exp. Eye Res."},{"key":"BFnrneurol201479_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00415-013-7141-6","volume":"261","author":"HM Kersten","year":"2014","unstructured":"Kersten, H. M. et al. Epiretinal membrane: a treatable cause of visual disability in myotonic dystrophy type 1. J. Neurol. 261, 37\u201344 (2014).","journal-title":"J. Neurol."},{"key":"BFnrneurol201479_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","volume":"30","author":"P Yu-Wai-Man","year":"2011","unstructured":"Yu-Wai-Man, P., Griffiths, P. G. & Chinnery, P. F. Mitochondrial optic neuropathies\u2014disease mechanisms and therapeutic strategies. Prog. Retin. Eye Res. 30, 81\u2013114 (2011).","journal-title":"Prog. Retin. Eye Res."},{"key":"BFnrneurol201479_CR12","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/ncpneuro0950","volume":"4","author":"EM Frohman","year":"2008","unstructured":"Frohman, E. M. et al. Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat. Clin. Pract. Neurol. 4, 664\u2013675 (2008).","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"BFnrneurol201479_CR13","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1126\/science.1957169","volume":"254","author":"D Huang","year":"1991","unstructured":"Huang, D. et al. Optical coherence tomography. Science 254, 1178\u20131181 (1991).","journal-title":"Science"},{"key":"BFnrneurol201479_CR14","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.ajo.2007.12.018","volume":"145","author":"DS Greenfield","year":"2008","unstructured":"Greenfield, D. S. & Weinreb, R. N. Role of optic nerve imaging in glaucoma clinical practice and clinical trials. Am. J. Ophthalmol. 145, 598\u2013603 (2008).","journal-title":"Am. J. Ophthalmol."},{"key":"BFnrneurol201479_CR15","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/IAE.0b013e31822a8fec","volume":"32","author":"P Milani","year":"2012","unstructured":"Milani, P., Raimondi, G., Morale, D. & Scialdone, A. Biomicroscopy versus optical coherence tomography screening of epiretinal membranes in patients undergoing cataract surgery. Retina 32, 897\u2013904 (2012).","journal-title":"Retina"},{"key":"BFnrneurol201479_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ajo.2009.01.024","volume":"148","author":"GA Lalwani","year":"2009","unstructured":"Lalwani, G. A. et al. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am. J. Ophthalmol. 148, 43\u201358.e1 (2009).","journal-title":"Am. J. Ophthalmol."},{"key":"BFnrneurol201479_CR17","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.1167\/iovs.13-12046","volume":"54","author":"E Marziani","year":"2013","unstructured":"Marziani, E. et al. Evaluation of retinal nerve fiber layer and ganglion cell layer thickness in Alzheimer's disease using spectral-domain optical coherence tomography. Invest. Ophthalmol. Vis. Sci. 54, 5953\u20135958 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BFnrneurol201479_CR18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/eye.2013.4","volume":"27","author":"M Satue","year":"2013","unstructured":"Satue, M. et al. Use of Fourier-domain OCT to detect retinal nerve fiber layer degeneration in Parkinson's disease patients. Eye (Lond.) 27, 507\u2013514 (2013).","journal-title":"Eye (Lond.)"},{"key":"BFnrneurol201479_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nrneurol.2012.273","volume":"9","author":"TJ Anderson","year":"2013","unstructured":"Anderson, T. J. & MacAskill, M. R. Eye movements in patients with neurodegenerative disorders. Nat. Rev. Neurol. 9, 74\u201385 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"BFnrneurol201479_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","volume":"1","author":"AE Emery","year":"1991","unstructured":"Emery, A. E. Population frequencies of inherited neuromuscular diseases\u2014a world survey. Neuromuscul. Disord. 1, 19\u201329 (1991).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol201479_CR21","first-page":"385","volume":"69","author":"JD Brook","year":"1992","unstructured":"Brook, J. D. et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3\u2032 end of a transcript encoding a protein kinase family member. Cell 69, 385 (1992).","journal-title":"Cell"},{"key":"BFnrneurol201479_CR22","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/355547a0","volume":"355","author":"J Buxton","year":"1992","unstructured":"Buxton, J. et al. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 355, 547\u2013548 (1992).","journal-title":"Nature"},{"key":"BFnrneurol201479_CR23","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1046\/j.1540-8167.2002.00444.x","volume":"13","author":"WJ Groh","year":"2002","unstructured":"Groh, W. J., Lowe, M. R. & Zipes, D. P. Severity of cardiac conduction involvement and arrhythmias in myotonic dystrophy type 1 correlates with age and CTG repeat length. J. Cardiovasc. Electrophysiol. 13, 444\u2013448 (2002).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrneurol201479_CR24","first-page":"1164","volume":"52","author":"HG Harley","year":"1993","unstructured":"Harley, H. G. et al. Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am. J. Hum. Genet. 52, 1164\u20131174 (1993).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol201479_CR25","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ophtha.2010.06.020","volume":"118","author":"N Rosa","year":"2011","unstructured":"Rosa, N. et al. Low intraocular pressure resulting from ciliary body detachment in patients with myotonic dystrophy. Ophthalmology 118, 260\u2013264 (2011).","journal-title":"Ophthalmology"},{"key":"BFnrneurol201479_CR26","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/0002-9394(71)90008-0","volume":"72","author":"MG Betten","year":"1971","unstructured":"Betten, M. G., Bilchik, R. C. & Smith, M. E. Pigmentary retinopathy of myotonic dystrophy. Am. J. Ophthalmol. 72, 720\u2013723 (1971).","journal-title":"Am. J. Ophthalmol."},{"key":"BFnrneurol201479_CR27","first-page":"289","volume":"17","author":"J Eshaghian","year":"1978","unstructured":"Eshaghian, J., March, W. F., Goossens, W. & Rafferty, N. S. Ultrastructure of cataract in myotonic dystrophy. Invest. Ophthalmol. Vis. Sci. 17, 289\u2013293 (1978).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BFnrneurol201479_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3109\/01676830.2012.736599","volume":"32","author":"M Doherty","year":"2013","unstructured":"Doherty, M., Winterton, R. & Griffiths, P. G. Eyelid surgery in ocular myopathies. Orbit 32, 12\u201315 (2013).","journal-title":"Orbit"},{"key":"BFnrneurol201479_CR29","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1126\/science.1062125","volume":"293","author":"CL Liquori","year":"2001","unstructured":"Liquori, C. L. et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293, 864\u2013867 (2001).","journal-title":"Science"},{"key":"BFnrneurol201479_CR30","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11910-002-0074-6","volume":"2","author":"LP Ranum","year":"2002","unstructured":"Ranum, L. P. & Day, J. W. Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2. Curr. Neurol. Neurosci. Rep. 2, 465\u2013470 (2002).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"BFnrneurol201479_CR31","first-page":"1021","volume":"10","author":"J Ginsberg","year":"1978","unstructured":"Ginsberg, J., Hamblet, J. & Menefee, M. Ocular abnormality in myotonic dystrophy. Ann. Ophthalmol. 10, 1021\u20131028 (1978).","journal-title":"Ann. Ophthalmol."},{"key":"BFnrneurol201479_CR32","volume-title":"Ocular Pathology: A Text and Atlas","author":"M Yanoff","year":"1982","unstructured":"Yanoff, M. & Fine, B. S. Ocular Pathology: A Text and Atlas 2nd edn (Harper & Row, 1982)."},{"key":"BFnrneurol201479_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1442-9071.1985.tb00395.x","volume":"13","author":"J Sarks","year":"1985","unstructured":"Sarks, J. et al. Retinal changes in myotonic dystrophy: a clinicomorphological study. Aust. N. Z. J. Ophthalmol. 13, 19\u201336 (1985).","journal-title":"Aust. N. Z. J. Ophthalmol."},{"key":"BFnrneurol201479_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/0002-9394(67)90577-6","volume":"63","author":"HM Burian","year":"1967","unstructured":"Burian, H. M. & Burns, C. A. Ocular changes in myotonic dystrophy. Am. J. Ophthalmol. 63, 22\u201334 (1967).","journal-title":"Am. J. Ophthalmol."},{"key":"BFnrneurol201479_CR35","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1136\/bjo.2005.085142","volume":"90","author":"SM Ghazi-Nouri","year":"2006","unstructured":"Ghazi-Nouri, S. M., Tranos, P. G., Rubin, G. S., Adams, Z. C. & Charteris, D. G. Visual function and quality of life following vitrectomy and epiretinal membrane peel surgery. Br. J. Ophthalmol. 90, 559\u2013562 (2006).","journal-title":"Br. J. Ophthalmol."},{"key":"BFnrneurol201479_CR36","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S0002-9394(00)00799-6","volume":"131","author":"J Gamez","year":"2001","unstructured":"Gamez, J., Montane, D., Martorell, L., Minoves, T. & Cervera, C. Bilateral optic nerve atrophy in myotonic dystrophy. Am. J. Ophthalmol. 131, 398\u2013400 (2001).","journal-title":"Am. J. Ophthalmol."},{"key":"BFnrneurol201479_CR37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ajmg.1320420113","volume":"42","author":"T Ashizawa","year":"1992","unstructured":"Ashizawa, T. et al. Diagnostic value of ophthalmologic findings in myotonic dystrophy: comparison with risks calculated by haplotype analysis of closely linked restriction fragment length polymorphisms. Am. J. Med. Genet. 42, 55\u201360 (1992).","journal-title":"Am. J. Med. Genet."},{"key":"BFnrneurol201479_CR38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.spen.2006.06.002","volume":"13","author":"U Schara","year":"2006","unstructured":"Schara, U. & Schoser, B. G. Myotonic dystrophies type 1 and 2: a summary on current aspects. Semin. Pediatr. Neurol. 13, 71\u201379 (2006).","journal-title":"Semin. Pediatr. Neurol."},{"key":"BFnrneurol201479_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000303921","volume":"141","author":"TA Vos","year":"1961","unstructured":"Vos, T. A. 25 years dystrophia myotonica (D.M.). Ophthalmologica 141, 37\u201345 (1961).","journal-title":"Ophthalmologica"},{"key":"BFnrneurol201479_CR40","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1001\/archopht.1984.01040030072039","volume":"102","author":"S Hayasaka","year":"1984","unstructured":"Hayasaka, S. et al. Ciliary and retinal changes in myotonic dystrophy. Arch. Ophthalmol. 102, 88\u201393 (1984).","journal-title":"Arch. Ophthalmol."},{"key":"BFnrneurol201479_CR41","first-page":"3131","volume":"34","author":"AR Khan","year":"1993","unstructured":"Khan, A. R. & Brubaker, R. F. Aqueous humor flow and flare in patients with myotonic dystrophy. Invest. Ophthalmol. Vis. Sci. 34, 3131\u20133139 (1993).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BFnrneurol201479_CR42","first-page":"744","volume":"22","author":"SD Walker","year":"1982","unstructured":"Walker, S. D., Brubaker, R. F. & Nagataki, S. Hypotony and aqueous humor dynamics in myotonic dystrophy. Invest. Ophthalmol. Vis. Sci. 22, 744\u2013751 (1982).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BFnrneurol201479_CR43","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ophtha.2009.07.003","volume":"117","author":"N Rosa","year":"2010","unstructured":"Rosa, N. et al. Corneal thickness and endothelial cell characteristics in patients with myotonic dystrophy. Ophthalmology 117, 223\u2013225 (2010).","journal-title":"Ophthalmology"},{"key":"BFnrneurol201479_CR44","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0161-6420(02)01009-6","volume":"109","author":"VA Wong","year":"2002","unstructured":"Wong, V. A., Beckingsale, P. S., Oley, C. A. & Sullivan, T. J. Management of myogenic ptosis. Ophthalmology 109, 1023\u20131031 (2002).","journal-title":"Ophthalmology"},{"key":"BFnrneurol201479_CR45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jaapos.2007.08.005","volume":"12","author":"KE Bollinger","year":"2008","unstructured":"Bollinger, K. E. et al. Hypermetropia and esotropia in myotonic dystrophy. J. AAPOS 12, 69\u201371 (2008).","journal-title":"J. AAPOS"},{"key":"BFnrneurol201479_CR46","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.ophtha.2010.01.055","volume":"117","author":"A-B Ekstrom","year":"2010","unstructured":"Ekstrom, A.-B., Tulinius, M., Sjostrom, A. & Aring, E. Visual function in congenital and childhood myotonic dystrophy type 1. Ophthalmology 117, 976\u2013982 (2010).","journal-title":"Ophthalmology"},{"key":"BFnrneurol201479_CR47","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.nurt.2008.07.005","volume":"5","author":"R Tawil","year":"2008","unstructured":"Tawil, R. Facioscapulohumeral muscular dystrophy. Neurotherapeutics 5, 601\u2013606 (2008).","journal-title":"Neurotherapeutics"},{"key":"BFnrneurol201479_CR48","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/ana.410430303","volume":"43","author":"R Tawil","year":"1998","unstructured":"Tawil, R., Figlewicz, D. A., Griggs, R. C. & Weiffenbach, B. Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. FSH Consortium. Ann. Neurol. 43, 279\u2013282 (1998).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201479_CR49","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/0140-6736(90)92148-B","volume":"336","author":"C Wijmenga","year":"1990","unstructured":"Wijmenga, C. et al. Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet 336, 651\u2013653 (1990).","journal-title":"Lancet"},{"key":"BFnrneurol201479_CR50","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1093\/hmg\/2.12.2037","volume":"2","author":"JC van Deutekom","year":"1993","unstructured":"van Deutekom, J. C. et al. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum. Mol. Genet. 2, 2037\u20132042 (1993).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol201479_CR51","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1093\/hmg\/3.10.1801","volume":"3","author":"U Bengtsson","year":"1994","unstructured":"Bengtsson, U., Altherr, M. R., Wasmuth, J. J. & Winokur, S. T. High resolution fluorescence in situ hybridization to linearly extended DNA visually maps a tandem repeat associated with facioscapulohumeral muscular dystrophy immediately adjacent to the telomere of 4q. Hum. Mol. Genet. 3, 1801\u20131805 (1994).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol201479_CR52","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1001\/archopht.1985.01050110089033","volume":"103","author":"EB Gurwin","year":"1985","unstructured":"Gurwin, E. B., Fitzsimons, R. B., Sehmi, K. S. & Bird, A. C. Retinal telangiectasis in facioscapulohumeral muscular dystrophy with deafness. Arch. Ophthalmol. 103, 1695\u20131700 (1985).","journal-title":"Arch. Ophthalmol."},{"key":"BFnrneurol201479_CR53","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/ana.410120414","volume":"12","author":"DA Taylor","year":"1982","unstructured":"Taylor, D. A. et al. Facioscapulohumeral dystrophy associated with hearing loss and Coats syndrome. Ann. Neurol. 12, 395\u2013398 (1982).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201479_CR54","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.nmd.2006.06.012","volume":"16","author":"LA Bindoff","year":"2006","unstructured":"Bindoff, L. A. et al. Severe fascioscapulohumeral muscular dystrophy presenting with Coats' disease and mental retardation. Neuromuscul. Disord. 16, 559\u2013563 (2006).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol201479_CR55","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1001\/archopht.125.6.840","volume":"125","author":"CL Shields","year":"2007","unstructured":"Shields, C. L. et al. Neovascular glaucoma from advanced Coats disease as the initial manifestation of facioscapulohumeral dystrophy in a 2-year-old child. Arch. Ophthalmol. 125, 840\u2013842 (2007).","journal-title":"Arch. Ophthalmol."},{"key":"BFnrneurol201479_CR56","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.nmd.2011.02.002","volume":"21","author":"RB Fitzsimons","year":"2011","unstructured":"Fitzsimons, R. B. Retinal vascular disease and the pathogenesis of facioscapulohumeral muscular dystrophy. A signalling message from Wnt? Neuromuscul. Disord. 21, 263\u2013271 (2011).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol201479_CR57","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.ophtha.2012.12.046","volume":"120","author":"N Rosa","year":"2013","unstructured":"Rosa, N. et al. Intraocular pressure in patients with muscular dystrophies. Ophthalmology 120, 1306\u20131307.e1 (2013).","journal-title":"Ophthalmology"},{"key":"BFnrneurol201479_CR58","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1474-4422(02)00042-X","volume":"1","author":"ME Shy","year":"2002","unstructured":"Shy, M. E., Garbern, J. Y. & Kamholz, J. Hereditary motor and sensory neuropathies: a biological perspective. Lancet Neurol. 1, 110\u2013118 (2002).","journal-title":"Lancet Neurol."},{"key":"BFnrneurol201479_CR59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ncpneuro0071","volume":"2","author":"S Zuchner","year":"2006","unstructured":"Zuchner, S. & Vance, J. M. Mechanisms of disease: a molecular genetic update on hereditary axonal neuropathies. Nat. Clin. Pract. Neurol. 2, 45\u201353 (2006).","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"BFnrneurol201479_CR60","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/S1474-4422(09)70110-3","volume":"8","author":"D Pareyson","year":"2009","unstructured":"Pareyson, D. & Marchesi, C. Diagnosis, natural history, and management of Charcot\u2013Marie\u2013Tooth disease. Lancet Neurol. 8, 654\u2013667 (2009).","journal-title":"Lancet Neurol."},{"key":"BFnrneurol201479_CR61","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.expneurol.2012.01.010","volume":"246","author":"V Timmerman","year":"2013","unstructured":"Timmerman, V., Clowes, V. E. & Reid, E. Overlapping molecular pathological themes link Charcot\u2013Marie\u2013Tooth neuropathies and hereditary spastic paraplegias. Exp. Neurol. 246, 14\u201325 (2013).","journal-title":"Exp. Neurol."},{"key":"BFnrneurol201479_CR62","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1055\/s-0032-1329198","volume":"32","author":"J Li","year":"2012","unstructured":"Li, J. Inherited neuropathies. Semin. Neurol. 32, 204\u2013214 (2012).","journal-title":"Semin. Neurol."},{"key":"BFnrneurol201479_CR63","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ana.20797","volume":"59","author":"S Zuchner","year":"2006","unstructured":"Zuchner, S. et al. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann. Neurol. 59, 276\u2013281 (2006).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201479_CR64","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/ng1341","volume":"36","author":"S Zuchner","year":"2004","unstructured":"Zuchner, S. et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot\u2013Marie\u2013Tooth neuropathy type 2A. Nat. Genet. 36, 449\u2013451 (2004).","journal-title":"Nat. Genet."},{"key":"BFnrneurol201479_CR65","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1093\/hmg\/ddi149","volume":"14","author":"S Pich","year":"2005","unstructured":"Pich, S. et al. The Charcot\u2013Marie\u2013Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum. Mol. Genet. 14, 1405\u20131415 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol201479_CR66","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ceb.2006.06.004","volume":"18","author":"H Chen","year":"2006","unstructured":"Chen, H. & Chan, D. C. Critical dependence of neurons on mitochondrial dynamics. Curr. Opin. Cell Biol. 18, 453\u2013459 (2006).","journal-title":"Curr. Opin. Cell Biol."},{"key":"BFnrneurol201479_CR67","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ana.21086","volume":"61","author":"D Loiseau","year":"2007","unstructured":"Loiseau, D. et al. Mitochondrial coupling defect in Charcot\u2013Marie\u2013Tooth type 2A disease. Ann. Neurol. 61, 315\u2013323 (2007).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201479_CR68","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00415-008-0847-1","volume":"255","author":"K Brockmann","year":"2008","unstructured":"Brockmann, K. et al. Cerebral involvement in axonal Charcot\u2013Marie\u2013Tooth neuropathy caused by mitofusin2 mutations. J. Neurol. 255, 1049\u20131058 (2008).","journal-title":"J. Neurol."},{"key":"BFnrneurol201479_CR69","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/eye.2008.221","volume":"23","author":"H Houlden","year":"2009","unstructured":"Houlden, H., Reilly, M. M. & Smith, S. Pupil abnormalities in 131 cases of genetically defined inherited peripheral neuropathy. Eye (Lond.) 23, 966\u2013974 (2009).","journal-title":"Eye (Lond.)"},{"key":"BFnrneurol201479_CR70","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/brain\/awq007","volume":"133","author":"P Yu-Wai-Man","year":"2010","unstructured":"Yu-Wai-Man, P. et al. Multi-system neurological disease is common in patients with OPA1 mutations. Brain 133, 771\u2013786 (2010).","journal-title":"Brain"},{"key":"BFnrneurol201479_CR71","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3109\/13816810.2011.587859","volume":"32","author":"S Gowrisankaran","year":"2011","unstructured":"Gowrisankaran, S., Anastasakis, A., Fishman, G. A. & Alexander, K. R. Structural and functional measures of inner retinal integrity following visual acuity improvement in a patient with hereditary motor and sensory neuropathy type VI. Ophthalmic Genet. 32, 188\u2013192 (2011).","journal-title":"Ophthalmic Genet."},{"key":"BFnrneurol201479_CR72","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1126\/science.271.5254.1423","volume":"271","author":"V Campuzano","year":"1996","unstructured":"Campuzano, V. et al. Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271, 1423\u20131427 (1996).","journal-title":"Science"},{"key":"BFnrneurol201479_CR73","first-page":"1","volume":"61","author":"AE Harding","year":"1993","unstructured":"Harding, A. E. Clinical features and classification of inherited ataxias. Adv. Neurol. 61, 1\u201314 (1993).","journal-title":"Adv. Neurol."},{"key":"BFnrneurol201479_CR74","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1056\/NEJM199610173351601","volume":"335","author":"A Durr","year":"1996","unstructured":"Durr, A. et al. Clinical and genetic abnormalities in patients with Friedreich's ataxia. N. Engl. J. Med. 335, 1169\u20131175 (1996).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol201479_CR75","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.freeradbiomed.2011.05.009","volume":"51","author":"JL Dunaief","year":"2011","unstructured":"Dunaief, J. L. Ironing out neurodegeneration: iron chelation for neuroprotection. Free Radic. Biol. Med. 51, 1480\u20131481 (2011).","journal-title":"Free Radic. Biol. Med."},{"key":"BFnrneurol201479_CR76","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/brain\/awm323","volume":"131","author":"MC Fahey","year":"2008","unstructured":"Fahey, M. C. et al. Vestibular, saccadic and fixation abnormalities in genetically confirmed Friedreich ataxia. Brain 131, 1035\u20131045 (2008).","journal-title":"Brain"},{"key":"BFnrneurol201479_CR77","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1001\/archneur.1983.04050060043006","volume":"40","author":"JM Furman","year":"1983","unstructured":"Furman, J. M., Perlman, S. & Baloh, R. W. Eye movements in Friedreich's ataxia. Arch. Neurol. 40, 343\u2013346 (1983).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201479_CR78","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s12311-010-0178-5","volume":"9","author":"DR Hocking","year":"2010","unstructured":"Hocking, D. R. et al. Ocular motor fixation deficits in Friedreich ataxia. Cerebellum 9, 411\u2013418 (2010).","journal-title":"Cerebellum"},{"key":"BFnrneurol201479_CR79","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/BF00867423","volume":"242","author":"S Spieker","year":"1995","unstructured":"Spieker, S. et al. Fixation instability and oculomotor abnormalities in Friedreich's ataxia. J. Neurol. 242, 517\u2013521 (1995).","journal-title":"J. Neurol."},{"key":"BFnrneurol201479_CR80","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/brain\/103.2.413","volume":"103","author":"WM Carroll","year":"1980","unstructured":"Carroll, W. M., Kriss, A., Baraitser, M., Barrett, G. & Halliday, A. M. The incidence and nature of visual pathway involvement in Friedreich's ataxia. A clinical and visual evoked potential study of 22 patients. Brain 103, 413\u2013434 (1980).","journal-title":"Brain"},{"key":"BFnrneurol201479_CR81","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/eye.2011.291","volume":"26","author":"S Noval","year":"2012","unstructured":"Noval, S., Contreras, I., Sanz-Gallego, I., Manrique, R. K. & Arpa, J. Ophthalmic features of Friedreich ataxia. Eye (Lond.) 26, 315\u2013320 (2012).","journal-title":"Eye (Lond.)"},{"key":"BFnrneurol201479_CR82","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1007\/s00415-013-6978-z","volume":"260","author":"LA Seyer","year":"2013","unstructured":"Seyer, L. A. et al. Analysis of the visual system in Friedreich ataxia. J. Neurol. 260, 2362\u20132369 (2013).","journal-title":"J. Neurol."},{"key":"BFnrneurol201479_CR83","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/brain\/awl081","volume":"129","author":"AM Duenas","year":"2006","unstructured":"Duenas, A. M., Goold, R. & Giunti, P. Molecular pathogenesis of spinocerebellar ataxias. Brain 129, 1357\u20131370 (2006).","journal-title":"Brain"},{"key":"BFnrneurol201479_CR84","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/WNO0b013e3181b416de","volume":"29","author":"HL Paulson","year":"2009","unstructured":"Paulson, H. L. The spinocerebellar ataxias. J. Neuroophthalmol. 29, 227\u2013237 (2009).","journal-title":"J. Neuroophthalmol."},{"key":"BFnrneurol201479_CR85","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/00041327-200212000-00007","volume":"22","author":"DR Lynch","year":"2002","unstructured":"Lynch, D. R. & Farmer, J. Practical approaches to neurogenetic disease. J. Neuroophthalmol. 22, 297\u2013304 (2002).","journal-title":"J. Neuroophthalmol."},{"key":"BFnrneurol201479_CR86","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/brain\/117.1.15","volume":"117","author":"C Moschner","year":"1994","unstructured":"Moschner, C., Perlman, S. & Baloh, R. W. Comparison of oculomotor findings in the progressive ataxia syndromes. Brain 117, 15\u201325 (1994).","journal-title":"Brain"},{"key":"BFnrneurol201479_CR87","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/14734220510007914","volume":"4","author":"M-U Manto","year":"2005","unstructured":"Manto, M.-U. The wide spectrum of spinocerebellar ataxias (SCAs). Cerebellum 4, 2\u20136 (2005).","journal-title":"Cerebellum"},{"key":"BFnrneurol201479_CR88","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1001\/jamaophthalmol.2013.1127","volume":"131","author":"V Vaclavik","year":"2013","unstructured":"Vaclavik, V., Borruat, F.-X., Ambresin, A. & Munier, F. L. Novel maculopathy in patients with spinocerebellar ataxia type 1 autofluorescence findings and functional characteristics. JAMA Ophthalmol. 131, 536\u2013538 (2013).","journal-title":"JAMA Ophthalmol."},{"key":"BFnrneurol201479_CR89","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1001\/archopht.1997.01100150233013","volume":"115","author":"T Abe","year":"1997","unstructured":"Abe, T., Abe, K., Aoki, M., Itoyama, Y. & Tamai, M. Ocular changes in patients with spinocerebellar degeneration and repeated trinucleotide expansion of spinocerebellar ataxia type 1 gene. Arch. Ophthalmol. 115, 231\u2013236 (1997).","journal-title":"Arch. Ophthalmol."},{"key":"BFnrneurol201479_CR90","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1001\/archneur.60.6.858","volume":"60","author":"WY Lee","year":"2003","unstructured":"Lee, W. Y. et al. Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients. Arch. Neurol. 60, 858\u2013863 (2003).","journal-title":"Arch. Neurol."},{"issue":"7","key":"BFnrneurol201479_CR91","doi-asserted-by":"publisher","first-page":"e23024","DOI":"10.1371\/journal.pone.0023024","volume":"6","author":"Sarah Stricker","year":"2011","unstructured":"Stricker, S. et al. Temporal retinal nerve fiber loss in patients with spinocerebellar ataxia type 1. PLoS ONE 6 (2011).","journal-title":"PLoS ONE"},{"key":"BFnrneurol201479_CR92","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/archneur.1978.00500270038008","volume":"35","author":"S Pogacar","year":"1978","unstructured":"Pogacar, S., Ambler, M., Conklin, W. J., O'Neil, W. A. & Lee, H. Y. Dominant spinopontine atrophy. Report of two additional members of family W. Arch. Neurol. 35, 156\u2013162 (1978).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201479_CR93","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/eye.2013.201","volume":"27","author":"G Alvarez","year":"2013","unstructured":"Alvarez, G. et al. Optical coherence tomography findings in spinocerebellar ataxia-3. Eye (Lond.) 27, 1376\u20131381 (2013).","journal-title":"Eye (Lond.)"},{"key":"BFnrneurol201479_CR94","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1001\/archneur.58.6.899","volume":"58","author":"LB Jardim","year":"2001","unstructured":"Jardim, L. B. et al. Neurologic findings in Machado\u2013Joseph disease: relation with disease duration, subtypes, and (CAG)n . Arch. Neurol. 58, 899\u2013904 (2001).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201479_CR95","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3109\/01658107.2011.580898","volume":"35","author":"JH Pula","year":"2011","unstructured":"Pula, J. H. et al. Retinal nerve fibre layer and macular thinning in spinocerebellar ataxia and cerebellar multisystem atrophy. Neuroophthalmology 35, 108\u2013114 (2011).","journal-title":"Neuroophthalmology"},{"key":"BFnrneurol201479_CR96","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/WNO.0b013e3181b1b3f8","volume":"29","author":"RC Miller","year":"2009","unstructured":"Miller, R. C., Tewari, A., Miller, J. A., Garbern, J. & Van Stavern, G. P. Neuro-ophthalmologic features of spinocerebellar ataxia type 7. J. Neuroophthalmology 29, 180\u2013186 (2009).","journal-title":"J. Neuroophthalmology"},{"key":"BFnrneurol201479_CR97","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/sj.ejhg.5201108","volume":"12","author":"A Michalik","year":"2004","unstructured":"Michalik, A., Martin, J. J. & Van Broeckhoven, C. Spinocerebellar ataxia type 7 associated with pigmentary retinal dystrophy. Eur. J. Hum. Genet. 12, 2\u201315 (2004).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFnrneurol201479_CR98","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/WNO.0b013e3181b41764","volume":"29","author":"MJ Thurtell","year":"2009","unstructured":"Thurtell, M. J. et al. Two patients with spinocerebellar ataxia type 7 presenting with profound binocular visual loss yet minimal ophthalmoscopic findings. J. Neuroophthalmol. 29, 187\u2013191 (2009).","journal-title":"J. Neuroophthalmol."},{"key":"BFnrneurol201479_CR99","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.ajo.2004.10.055","volume":"139","author":"JK Ahn","year":"2005","unstructured":"Ahn, J. K., Seo, J.-M., Chung, H. & Yu, H. G. Anatomical and functional characteristics in atrophic maculopathy associated with spinocerebellar ataxia type 7. Am. J. Ophthalmol. 139, 923\u2013925 (2005).","journal-title":"Am. J. Ophthalmol."},{"key":"BFnrneurol201479_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13816810802454081","volume":"30","author":"T Hugosson","year":"2009","unstructured":"Hugosson, T., Granse, L., Ponjavic, V. & Andreasson, S. Macular dysfunction and morphology in spinocerebellar ataxia type 7 (SCA 7). Ophthalmic Genet. 30, 1\u20136 (2009).","journal-title":"Ophthalmic Genet."},{"key":"BFnrneurol201479_CR101","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s12311-012-0412-4","volume":"12","author":"LC Horton","year":"2013","unstructured":"Horton, L. C. et al. Spinocerebellar ataxia type 7: clinical course, phenotype\u2013genotype correlations, and neuropathology. Cerebellum 12, 176\u2013193 (2013).","journal-title":"Cerebellum"},{"key":"BFnrneurol201479_CR102","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S0960-8966(98)00055-8","volume":"8","author":"JP Bouchard","year":"1998","unstructured":"Bouchard, J. P. et al. Autosomal recessive spastic ataxia of Charlevoix-Saguenay. Neuromuscul. Disord. 8, 474\u2013479 (1998).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrneurol201479_CR103","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1212\/WNL.0b013e318200d7f8","volume":"75","author":"M Gerwig","year":"2010","unstructured":"Gerwig, M. et al. Characteristic MRI and funduscopic findings help diagnose ARSACS outside Quebec. Neurology 75, 2133 (2010).","journal-title":"Neurology"},{"key":"BFnrneurol201479_CR104","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1440-1789.2006.00664.x","volume":"26","author":"Y Takiyama","year":"2006","unstructured":"Takiyama, Y. Autosomal recessive spastic ataxia of Charlevoix-Saguenay. Neuropathology 26, 368\u2013375 (2006).","journal-title":"Neuropathology"},{"key":"BFnrneurol201479_CR105","doi-asserted-by":"publisher","first-page":"7137","DOI":"10.1167\/iovs.13-12726","volume":"54","author":"E Garcia-Martin","year":"2013","unstructured":"Garcia-Martin, E. et al. Retinal segmentation as noninvasive technique to demonstrate hyperplasia in ataxia of Charlevoix-Saguenay. Invest. Ophthalmol. Vis. Sci. 54, 7137\u20137142 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BFnrneurol201479_CR106","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1212\/WNL.0b013e3181f4d86c","volume":"75","author":"J Baets","year":"2010","unstructured":"Baets, J. et al. Mutations in SACS cause atypical and late-onset forms of ARSACS. Neurology 75, 1181\u20131188 (2010).","journal-title":"Neurology"},{"key":"BFnrneurol201479_CR107","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1212\/01.WNL.0000099371.14478.73","volume":"62","author":"T Ogawa","year":"2004","unstructured":"Ogawa, T. et al. Identification of a SACS gene missense mutation in ARSACS. Neurology 62, 107\u2013109 (2004).","journal-title":"Neurology"},{"key":"BFnrneurol201479_CR108","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/bjophthalmol-2012-302309","volume":"97","author":"E Garcia-Martin","year":"2013","unstructured":"Garcia-Martin, E. et al. Retinal nerve fibre layer thickness in ARSACS: myelination or hypertrophy? Br. J. Ophthalmol. 97, 238\u2013241 (2013).","journal-title":"Br. J. Ophthalmol."},{"key":"BFnrneurol201479_CR109","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/j.1468-1331.2010.03335.x","volume":"18","author":"EM Vingolo","year":"2011","unstructured":"Vingolo, E. M. et al. Myelinated retinal fibers in autosomal recessive spastic ataxia of Charlevoix-Saguenay. Eur. J. Neurol. 18, 1187\u20131190 (2011).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol201479_CR110","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s12311-011-0286-x","volume":"10","author":"J Desserre","year":"2011","unstructured":"Desserre, J. et al. Thickening of peripapillar retinal fibers for the diagnosis of autosomal recessive spastic ataxia of Charlevoix-Saguenay. Cerebellum 10, 758\u2013762 (2011).","journal-title":"Cerebellum"},{"key":"BFnrneurol201479_CR111","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1073\/pnas.1113166109","volume":"109","author":"M Girard","year":"2012","unstructured":"Girard, M. et al. Mitochondrial dysfunction and Purkinje cell loss in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). Proc. Natl Acad. Sci. USA 109, 1661\u20131666 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrneurol201479_CR112","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(83)92879-9","volume":"1","author":"AE Harding","year":"1983","unstructured":"Harding, A. E. Classification of the hereditary ataxias and paraplegias. Lancet 1, 1151\u20131155 (1983).","journal-title":"Lancet"},{"key":"BFnrneurol201479_CR113","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/S1474-4422(08)70258-8","volume":"7","author":"S Salinas","year":"2008","unstructured":"Salinas, S., Proukakis, C., Crosby, A. & Warner, T. T. Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms. Lancet Neurol. 7, 1127\u20131138 (2008).","journal-title":"Lancet Neurol."},{"key":"BFnrneurol201479_CR114","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1055\/s-0031-1299787","volume":"31","author":"R Schule","year":"2011","unstructured":"Schule, R. & Schols, L. Genetics of hereditary spastic paraplegias. Semin. Neurol. 31, 484\u2013493 (2011).","journal-title":"Semin. Neurol."},{"key":"BFnrneurol201479_CR115","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00401-013-1115-8","volume":"126","author":"JK Fink","year":"2013","unstructured":"Fink, J. K. Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. Acta Neuropathol. 126, 307\u2013328 (2013).","journal-title":"Acta Neuropathol."},{"key":"BFnrneurol201479_CR116","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1007\/s00415-012-6792-z","volume":"260","author":"RH Roxburgh","year":"2013","unstructured":"Roxburgh, R. H. et al. The p.Ala510Val mutation in the SPG7 (paraplegin) gene is the most common mutation causing adult onset neurogenetic disease in patients of British ancestry. J. Neurol. 260, 1286\u20131294 (2013).","journal-title":"J. Neurol."},{"key":"BFnrneurol201479_CR117","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1471-2377-12-143","volume":"12","author":"S Wiethoff","year":"2012","unstructured":"Wiethoff, S., Zhour, A., Sch\u00f6ls, L. & Fischer, M. D. Retinal nerve fibre layer loss in hereditary spastic paraplegias is restricted to complex phenotypes. BMC Neurol. 12, 143 (2012).","journal-title":"BMC Neurol."},{"key":"BFnrneurol201479_CR118","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S0092-8674(00)81203-9","volume":"93","author":"G Casari","year":"1998","unstructured":"Casari, G. et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93, 973\u2013983 (1998).","journal-title":"Cell"},{"key":"BFnrneurol201479_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbabio.2009.07.013","volume":"1797","author":"P Martinelli","year":"2010","unstructured":"Martinelli, P. & Rugarli, E. I. Emerging roles of mitochondrial proteases in neurodegeneration. Biochim. Biophys. Acta 1797, 1\u201310 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrneurol201479_CR120","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/sj.cdd.4402145","volume":"14","author":"L Pellegrini","year":"2007","unstructured":"Pellegrini, L. & Scorrano, L. A cut short to death: Parl and Opa1 in the regulation of mitochondrial morphology and apoptosis. Cell Death Differ. 14, 1275\u20131284 (2007).","journal-title":"Cell Death Differ."},{"key":"BFnrneurol201479_CR121","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/jmedgenet-2012-101212","volume":"49","author":"H Shimazaki","year":"2012","unstructured":"Shimazaki, H. et al. A homozygous mutation of C12orf65 causes spastic paraplegia with optic atrophy and neuropathy (SPG55). J. Med. Genet. 49, 777\u2013784 (2012).","journal-title":"J. Med. Genet."},{"key":"BFnrneurol201479_CR122","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/ng1980","volume":"39","author":"G Stevanin","year":"2007","unstructured":"Stevanin, G. et al. Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat. Genet. 39, 366\u2013372 (2007).","journal-title":"Nat. Genet."},{"key":"BFnrneurol201479_CR123","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.ajhg.2008.03.004","volume":"82","author":"S Hanein","year":"2008","unstructured":"Hanein, S. et al. Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal-recessive spastic paraplegia, including Kjellin syndrome. Am. J. Hum. Genet. 82, 992\u20131002 (2008).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol201479_CR124","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1136\/jnnp.63.5.628","volume":"63","author":"S Webb","year":"1997","unstructured":"Webb, S., Patterson, V. & Hutchinson, M. Two families with autosomal recessive spastic paraplegia, pigmented maculopathy, and dementia. J. Neurol. Neurosurg. Psychiatry 63, 628\u2013632 (1997).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol201479_CR125","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/WCO.0b013e3283550cac","volume":"25","author":"P Dusek","year":"2012","unstructured":"Dusek, P. & Schneider, S. A. Neurodegeneration with brain iron accumulation. Curr. Opin. Neurol. 25, 499\u2013506 (2012).","journal-title":"Curr. Opin. Neurol."},{"key":"BFnrneurol201479_CR126","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ajhg.2011.09.007","volume":"89","author":"MB Hartig","year":"2011","unstructured":"Hartig, M. B. et al. Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation. Am. J. Hum. Genet. 89, 543\u2013550 (2011).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol201479_CR127","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/mds.25271","volume":"28","author":"MA Dezfouli","year":"2013","unstructured":"Dezfouli, M. A. et al. PANK2 and C19orf12 mutations are common causes of neurodegeneration with brain iron accumulation. Mov. Disord. 28, 228\u2013232 (2013).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201479_CR128","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1177\/0883073807307092","volume":"22","author":"B Kazek","year":"2007","unstructured":"Kazek, B. et al. A novel PANK2 gene mutation: clinical and molecular characteristics of patients short communication. J. Child Neurol. 22, 1256\u20131259 (2007).","journal-title":"J. Child Neurol."},{"key":"BFnrneurol201479_CR129","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.2174\/138945012802002384","volume":"13","author":"MB Hartig","year":"2012","unstructured":"Hartig, M. B., Prokisch, H., Meitinger, T. & Klopstock, T. Pantothenate kinase-associated neurodegeneration. Curr. Drug Targets 13, 1182\u20131189 (2012).","journal-title":"Curr. Drug Targets"},{"key":"BFnrneurol201479_CR130","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng572","volume":"28","author":"B Zhou","year":"2001","unstructured":"Zhou, B. et al. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden\u2013Spatz syndrome. Nat. Genet. 28, 345\u2013349 (2001).","journal-title":"Nat. Genet."},{"key":"BFnrneurol201479_CR131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2152\/jmi.59.1","volume":"59","author":"Y Mitamura","year":"2012","unstructured":"Mitamura, Y. et al. Diagnostic imaging in patients with retinitis pigmentosa. J. Med. Invest. 59, 1\u201311 (2012).","journal-title":"J. Med. Invest."},{"key":"BFnrneurol201479_CR132","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/B978-0-12-410502-7.00004-1","volume":"110","author":"M Hartig","year":"2013","unstructured":"Hartig, M., Prokisch, H., Meitinger, T. & Klopstock, T. Mitochondrial membrane protein-associated neurodegeneration (MPAN). Int. Rev. Neurobiol. 110, 73\u201384 (2013).","journal-title":"Int. Rev. Neurobiol."},{"key":"BFnrneurol201479_CR133","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/mds.24980","volume":"27","author":"R Horvath","year":"2012","unstructured":"Horvath, R. et al. A new phenotype of brain iron accumulation with dystonia, optic atrophy, and peripheral neuropathy. Mov. Disord. 27, 789\u2013793 (2012).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201479_CR134","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.gene.2013.11.039","volume":"537","author":"MC Kruer","year":"2014","unstructured":"Kruer, M. C. et al. C19orf12 mutation leads to a pallido-pyramidal syndrome. Gene 537, 352\u2013356 (2014).","journal-title":"Gene"},{"key":"BFnrneurol201479_CR135","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/mds.25256","volume":"28","author":"EC Schulte","year":"2013","unstructured":"Schulte, E. C. et al. Mitochondrial membrane protein associated neurodegenration: a novel variant of neurodegeneration with brain iron accumulation. Mov. Disord. 28, 224\u2013227 (2013).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201479_CR136","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1001\/archophthalmol.2011.309","volume":"129","author":"N Wolkow","year":"2011","unstructured":"Wolkow, N. et al. Aceruloplasminemia: retinal histopathologic manifestations and iron-mediated melanosome degradation. Arch. Ophthalmol. 129, 1466\u20131474 (2011).","journal-title":"Arch. Ophthalmol."},{"key":"BFnrneurol201479_CR137","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1093\/brain\/120.8.1485","volume":"120","author":"HW Moser","year":"1997","unstructured":"Moser, H. W. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 120, 1485\u20131508 (1997).","journal-title":"Brain"},{"key":"BFnrneurol201479_CR138","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1586\/14737175.8.9.1367","volume":"8","author":"A Semmler","year":"2008","unstructured":"Semmler, A., Kohler, W., Jung, H. H., Weller, M. & Linnebank, M. Therapy of X-linked adrenoleukodystrophy. Expert Rev. Neurother. 8, 1367\u20131379 (2008).","journal-title":"Expert Rev. Neurother."},{"key":"BFnrneurol201479_CR139","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/361726a0","volume":"361","author":"J Mosser","year":"1993","unstructured":"Mosser, J. et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361, 726\u2013730 (1993).","journal-title":"Nature"},{"key":"BFnrneurol201479_CR140","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/archneur.1975.00490510033001","volume":"32","author":"HH Schaumburg","year":"1975","unstructured":"Schaumburg, H. H., Powers, J. M., Raine, C. S., Suzuki, K. & Richardson, E. P. Jr. Adrenoleukodystrophy. A clinical and pathological study of 17 cases. Arch. Neurol. 32, 577\u2013591 (1975).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201479_CR141","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/ana.410370419","volume":"37","author":"PW Kaplan","year":"1995","unstructured":"Kaplan, P. W. et al. Visual system abnormalities in adrenomyeloneuropathy. Ann. Neurol. 37, 550\u2013552 (1995).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201479_CR142","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0161-6420(87)33504-3","volume":"94","author":"EI Traboulsi","year":"1987","unstructured":"Traboulsi, E. I. & Maumenee, I. H. Ophthalmologic manifestations of X-linked childhood adrenoleukodystrophy. Ophthalmology 94, 47\u201352 (1987).","journal-title":"Ophthalmology"},{"key":"BFnrneurol201479_CR143","first-page":"794","volume":"44","author":"GH Sack Jr","year":"1989","unstructured":"Sack, G. H. Jr, Raven, M. B. & Moser, H. W. Color vision defects in adrenomyeloneuropathy. Am. J. Hum. Genet. 44, 794\u2013798 (1989).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol201479_CR144","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/0002-9394(76)90498-0","volume":"82","author":"SH Wray","year":"1976","unstructured":"Wray, S. H., Cogan, D. G., Kuwabara, T., Schaumburg, H. H. & Powers, J. M. Adrenoleukodystrophy with disease of the eye and optic nerve. Am. J. Ophthalmol. 82, 480\u2013485 (1976).","journal-title":"Am. J. Ophthalmol."},{"key":"BFnrneurol201479_CR145","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3109\/01658108109004916","volume":"1","author":"WB Wilson","year":"1981","unstructured":"Wilson, W. B. The visual system manifestations of adrenoleukodystrophy. Neuroophthalmology 1, 175\u2013183 (1981).","journal-title":"Neuroophthalmology"},{"key":"BFnrneurol201479_CR146","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/0002-9394(83)90384-7","volume":"95","author":"SM Cohen","year":"1983","unstructured":"Cohen, S. M. et al. Ocular histopathologic studies of neonatal and childhood adrenoleukodystrophy. Am. J. Ophthalmol. 95, 82\u201396 (1983).","journal-title":"Am. J. Ophthalmol."},{"key":"BFnrneurol201479_CR147","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0161-6420(87)33345-7","volume":"94","author":"BJ Glasgow","year":"1987","unstructured":"Glasgow, B. J., Brown, H. H., Hannah, J. B. & Foos, R. Y. Ocular pathologic findings in neonatal adrenoleukodystrophy. Ophthalmology 94, 1054\u20131060 (1987).","journal-title":"Ophthalmology"},{"key":"BFnrneurol201479_CR148","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.1132814","volume":"314","author":"M Goedert","year":"2006","unstructured":"Goedert, M. & Spillantini, M. G. A century of Alzheimer's disease. Science 314, 777\u2013781 (2006).","journal-title":"Science"},{"key":"BFnrneurol201479_CR149","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.arcmed.2012.10.017","volume":"43","author":"ME Alonso Vilatela","year":"2012","unstructured":"Alonso Vilatela, M. E., Lopez-Lopez, M. & Yescas-Gomez, P. Genetics of Alzheimer's disease. Arch. Med. Res. 43, 622\u2013631 (2012).","journal-title":"Arch. Med. Res."},{"key":"BFnrneurol201479_CR150","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1093\/hmg\/ddr381","volume":"20","author":"MJ Calkins","year":"2011","unstructured":"Calkins, M. J., Manczak, M., Mao, P., Shirendeb, U. & Reddy, P. H. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. Hum. Mol. Genet. 20, 4515\u20134529 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrneurol201479_CR151","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/0891988710383571","volume":"23","author":"LM Bekris","year":"2010","unstructured":"Bekris, L. M., Yu, C.-E., Bird, T. D. & Tsuang, D. W. Genetics of Alzheimer disease. J. Geriatr. Psychiatry Neurol. 23, 213\u2013227 (2010).","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"BFnrneurol201479_CR152","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1086\/302553","volume":"65","author":"D Campion","year":"1999","unstructured":"Campion, D. et al. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am. J. Hum. Genet. 65, 664\u2013670 (1999).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol201479_CR153","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neulet.2010.06.006","volume":"480","author":"Y Lu","year":"2010","unstructured":"Lu, Y. et al. Retinal nerve fiber layer structure abnormalities in early Alzheimer's disease: evidence in optical coherence tomography. Neurosci. Lett. 480, 69\u201372 (2010).","journal-title":"Neurosci. Lett."},{"key":"BFnrneurol201479_CR154","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1212\/01.wnl.0000244490.07925.8b","volume":"67","author":"HV Danesh-Meyer","year":"2006","unstructured":"Danesh-Meyer, H. V., Birch, H. F., Ku, J. Y., Carroll, S. M. & Gamble, G. M. Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging. Neurology 67, 1852\u20131854 (2006).","journal-title":"Neurology"},{"key":"BFnrneurol201479_CR155","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archopht.1991.01080020045040","volume":"109","author":"CS Tsai","year":"1991","unstructured":"Tsai, C. S. et al. Optic nerve head and nerve fiber layer in Alzheimer's disease. Arch. Ophthalmol. 109, 199\u2013204 (1991).","journal-title":"Arch. Ophthalmol."},{"key":"BFnrneurol201479_CR156","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/01.wno.0000204645.56873.26","volume":"26","author":"PK Iseri","year":"2006","unstructured":"Iseri, P. K., Altinas, O., Tokay, T. & Yuksel, N. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J. Neuroophthalmol. 26, 18\u201324 (2006).","journal-title":"J. Neuroophthalmol."},{"key":"BFnrneurol201479_CR157","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1167\/iovs.06-1029","volume":"48","author":"F Berisha","year":"2007","unstructured":"Berisha, F., Feke, G. T., Trempe, C. L., McMeel, J. W. & Schepens, C. L. Retinal abnormalities in early Alzheimer's disease. Invest. Ophthalmol. Vis. Sci. 48, 2285\u20132289 (2007).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"BFnrneurol201479_CR158","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.neulet.2007.02.090","volume":"420","author":"C Paquet","year":"2007","unstructured":"Paquet, C. et al. Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci. Lett. 420, 97\u201399 (2007).","journal-title":"Neurosci. Lett."},{"key":"BFnrneurol201479_CR159","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1212\/01.wnl.0000280584.64363.83","volume":"69","author":"DA Valenti","year":"2007","unstructured":"Valenti, D. A. Neuroimaging of retinal nerve fiber layer in AD using optical coherence tomography. Neurology 69, 1060 (2007).","journal-title":"Neurology"},{"key":"BFnrneurol201479_CR160","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.clineuro.2011.02.014","volume":"113","author":"A Kesler","year":"2011","unstructured":"Kesler, A., Vakhapova, V., Korczyn, A. D., Naftaliev, E. & Neudorfer, M. Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Clin. Neurol. Neurosurg. 113, 523\u2013526 (2011).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"BFnrneurol201479_CR161","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/WNO.0b013e318267fd5f","volume":"33","author":"S Kirbas","year":"2013","unstructured":"Kirbas, S., Turkyilmaz, K., Anlar, O., Tufekci, A. & Durmus, M. Retinal nerve fiber layer thickness in patients with Alzheimer disease. J. Neuroophthalmol. 33, 58\u201361 (2013).","journal-title":"J. Neuroophthalmol."},{"key":"BFnrneurol201479_CR162","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1098\/rstb.2008.2273","volume":"363","author":"Y Mizuno","year":"2008","unstructured":"Mizuno, Y. et al. Progress in the pathogenesis and genetics of Parkinson's disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 363, 2215\u20132227 (2008).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"BFnrneurol201479_CR163","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/mds.25249","volume":"28","author":"AB Singleton","year":"2013","unstructured":"Singleton, A. B., Farrer, M. J. & Bonifati, V. The genetics of Parkinson's disease: progress and therapeutic implications. Mov. Disord. 28, 14\u201323 (2013).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201479_CR164","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000334285","volume":"10","author":"S Fujioka","year":"2012","unstructured":"Fujioka, S. & Wszolek, Z. K. Update on genetics of parkinsonism. Neurodegener. Dis. 10, 257\u2013260 (2012).","journal-title":"Neurodegener. Dis."},{"key":"BFnrneurol201479_CR165","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10633-007-9091-8","volume":"116","author":"O Altintas","year":"2008","unstructured":"Altintas, O., Iseri, P., Ozkan, B. & Caglar, Y. Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc. Ophthalmol. 116, 137\u2013146 (2008).","journal-title":"Doc. Ophthalmol."},{"key":"BFnrneurol201479_CR166","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1002\/mds.23215","volume":"25","author":"E Cubo","year":"2010","unstructured":"Cubo, E., Tedejo, R. P., Rodriguez Mendez, V., Lopez Pena, M. J. & Trejo Gabriel Y Galan, J. M. Retina thickness in Parkinson's disease and essential tremor. Mov. Disord. 25, 2461\u20132462 (2010).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201479_CR167","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1468-1331.2012.03701.x","volume":"20","author":"C La Morgia","year":"2013","unstructured":"La Morgia, C. et al. Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern? Eur. J. Neurol. 20, 198\u2013201 (2013).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol201479_CR168","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1016\/j.visres.2004.06.009","volume":"44","author":"R Inzelberg","year":"2004","unstructured":"Inzelberg, R., Ramirez, J. A., Nisipeanu, P. & Ophir, A. Retinal nerve fiber layer thinning in Parkinson disease. Vision Res. 44, 2793\u20132797 (2004).","journal-title":"Vision Res."},{"key":"BFnrneurol201479_CR169","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.ophtha.2012.05.003","volume":"119","author":"E Garcia-Martin","year":"2012","unstructured":"Garcia-Martin, E. et al. Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease. Ophthalmology 119, 2161\u20132167 (2012).","journal-title":"Ophthalmology"},{"key":"BFnrneurol201479_CR170","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1136\/bjophthalmol-2013-304152","volume":"98","author":"M Satue","year":"2013","unstructured":"Satue, M. et al. Retinal thinning and correlation with functional disability in patients with Parkinson's disease. Br. J. Ophthalmol. 98, 350\u2013355 (2013).","journal-title":"Br. J. Ophthalmol."},{"key":"BFnrneurol201479_CR171","doi-asserted-by":"publisher","first-page":"e34891","DOI":"10.1371\/journal.pone.0034891","volume":"7","author":"P Albrecht","year":"2012","unstructured":"Albrecht, P. et al. Optical coherence tomography in parkinsonian syndromes. PLoS ONE 7, e34891 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrneurol201479_CR172","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1471-2415-12-54","volume":"12","author":"EE Tsironi","year":"2012","unstructured":"Tsironi, E. E. et al. Perimetric and retinal nerve fiber layer findings in patients with Parkinson's disease. BMC Ophthalmol. 12, 54 (2012).","journal-title":"BMC Ophthalmol."},{"key":"BFnrneurol201479_CR173","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.parkreldis.2011.03.004","volume":"17","author":"NK Archibald","year":"2011","unstructured":"Archibald, N. K., Clarke, M. P., Mosimann, U. P. & Burn, D. J. Retinal thickness in Parkinson's disease. Parkinsonism Relat. Disord. 17, 431\u2013436 (2011).","journal-title":"Parkinsonism Relat. Disord."},{"key":"BFnrneurol201479_CR174","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1002\/mds.23891","volume":"26","author":"NK Archibald","year":"2011","unstructured":"Archibald, N. K., Clarke, M. P., Mosimann, U. P. & Burn, D. J. Visual symptoms in Parkinson's disease and Parkinson's disease dementia. Mov. Disord. 26, 2387\u20132395 (2011).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201479_CR175","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/WNO.0b013e31828c4e1a","volume":"33","author":"CR Adam","year":"2013","unstructured":"Adam, C. R., Shrier, E., Ding, Y., Glazman, S. & Bodis-Wollner, I. Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease. J. Neuroophthalmol. 33, 137\u2013142 (2013).","journal-title":"J. Neuroophthalmol."},{"key":"BFnrneurol201479_CR176","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1212\/01.wnl.0000191565.11065.11","volume":"65","author":"EY Uc","year":"2005","unstructured":"Uc, E. Y. et al. Visual dysfunction in Parkinson disease without dementia. Neurology 65, 1907\u20131913 (2005).","journal-title":"Neurology"},{"key":"BFnrneurol201479_CR177","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/ana.410120614","volume":"12","author":"CN Karson","year":"1982","unstructured":"Karson, C. N., LeWitt, P. A., Calne, D. B. & Wyatt, R. J. Blink rates in Parkinsonism. Ann. Neurol. 12, 580\u2013583 (1982).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201479_CR178","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/mds.21887","volume":"23","author":"R Agostino","year":"2008","unstructured":"Agostino, R. et al. Voluntary, spontaneous, and reflex blinking in Parkinson's disease. Mov. Disord. 23, 669\u2013675 (2008).","journal-title":"Mov. Disord."},{"key":"BFnrneurol201479_CR179","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/ICO.0b013e3182574ade","volume":"32","author":"VC Reddy","year":"2013","unstructured":"Reddy, V. C., Patel, S. V., Hodge, D. O. & Leavitt, J. A. Corneal sensitivity, blink rate, and corneal nerve density in progressive supranuclear palsy and Parkinson disease. Cornea 32, 631\u2013635 (2013).","journal-title":"Cornea"},{"key":"BFnrneurol201479_CR180","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/ceo.12086","volume":"41","author":"AA Sadun","year":"2013","unstructured":"Sadun, A. A., La Morgia, C. & Carelli, V. Mitochondrial optic neuropathies: our travels from bench to bedside and back again. Clin. Experiment. Ophthalmol. 41, 702\u2013712 (2013).","journal-title":"Clin. Experiment. Ophthalmol."},{"key":"BFnrneurol201479_CR181","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.spen.2012.09.006","volume":"19","author":"S Debrosse","year":"2012","unstructured":"Debrosse, S. & Parikh, S. Neurologic disorders due to mitochondrial DNA mutations. Semin. Pediatr. Neurol. 19, 194\u2013202 (2012).","journal-title":"Semin. Pediatr. Neurol."},{"key":"BFnrneurol201479_CR182","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1126\/science.283.5407.1482","volume":"283","author":"DC Wallace","year":"1999","unstructured":"Wallace, D. C. Mitochondrial diseases in man and mouse. Science 283, 1482\u20131488 (1999).","journal-title":"Science"},{"key":"BFnrneurol201479_CR183","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s11910-012-0260-0","volume":"12","author":"KS Sitarz","year":"2012","unstructured":"Sitarz, K. S., Chinnery, P. F. & Yu-Wai-Man, P. Disorders of the optic nerve in mitochondrial cytopathies: new ideas on pathogenesis and therapeutic targets. Curr. Neurol. Neurosci. Rep. 12, 308\u2013317 (2012).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"BFnrneurol201479_CR184","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","volume":"23","author":"V Carelli","year":"2004","unstructured":"Carelli, V., Ross-Cisneros, F. N. & Sadun, A. A. Mitochondrial dysfunction as a cause of optic neuropathies. Prog. Retin. Eye Res. 23, 53\u201389 (2004).","journal-title":"Prog. Retin. Eye Res."},{"key":"BFnrneurol201479_CR185","first-page":"223","volume":"98","author":"AA Sadun","year":"2000","unstructured":"Sadun, A. A., Win, P. H., Ross-Cisneros, F. N., Walker, S. O. & Carelli, V. Leber's hereditary optic neuropathy differentially affects smaller axons in the optic nerve. Trans. Am. Ophthalmol. Soc. 98, 223\u2013232 (2000).","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"BFnrneurol201479_CR186","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1001\/archopht.120.6.791","volume":"120","author":"EA Bristow","year":"2002","unstructured":"Bristow, E. A., Griffiths, P. G., Andrews, R. M., Johnson, M. A. & Turnbull, D. M. The distribution of mitochondrial activity in relation to optic nerve structure. Arch. Ophthalmol. 120, 791\u2013796 (2002).","journal-title":"Arch. Ophthalmol."},{"key":"BFnrneurol201479_CR187","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ophtha.2004.09.033","volume":"112","author":"G Savini","year":"2005","unstructured":"Savini, G. et al. Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber's hereditary optic neuropathy mutations. Ophthalmology 112, 127\u2013131 (2005).","journal-title":"Ophthalmology"},{"key":"BFnrneurol201479_CR188","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s40263-013-0124-4","volume":"28","author":"J Liu","year":"2014","unstructured":"Liu, J. & Wang, L.-N. Mitochondrial enhancement for neurodegenerative movement disorders: a systematic review of trials involving creatine, coenzyme Q10, idebenone and mitoquinone. CNS Drugs 28, 63\u201368 (2014).","journal-title":"CNS Drugs"},{"key":"BFnrneurol201479_CR189","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1111\/bph.12516","volume":"171","author":"A Hall","year":"2014","unstructured":"Hall, A., Burke, N., Dongworth, R. K. & Hausenloy, D. J. Mitochondrial fusion and fission proteins: novel therapeutic targets for combating cardiovascular disease. Br. J. Pharmacol. 171, 1890\u20131906 (2014).","journal-title":"Br. J. Pharmacol."},{"key":"BFnrneurol201479_CR190","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/cr.2014.20","volume":"24","author":"W Yue","year":"2014","unstructured":"Yue, W. et al. A small natural molecule promotes mitochondrial fusion through inhibition of the deubiquitinase USP30. Cell Res. 24, 482\u2013496 (2014).","journal-title":"Cell Res."},{"key":"BFnrneurol201479_CR191","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0140-6736(13)62117-0","volume":"383","author":"RE MacLaren","year":"2014","unstructured":"MacLaren, R. E. et al. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1\/2 clinical trial. Lancet 383, 1129\u20131137 (2014).","journal-title":"Lancet"},{"key":"BFnrneurol201479_CR192","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.mcn.2012.08.004","volume":"55","author":"A Maresca","year":"2013","unstructured":"Maresca, A., la Morgia, C., Caporali, L., Valentino, M. L. & Carelli, V. The optic nerve: a \u201cmito-window\u201d on mitochondrial neurodegeneration. Mol. Cell. Neurosci. 55, 62\u201376 (2013).","journal-title":"Mol. Cell. Neurosci."},{"key":"BFnrneurol201479_CR193","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1001\/archneur.65.4.530","volume":"65","author":"P Christova","year":"2008","unstructured":"Christova, P., Anderson, J. H. & Gomez, C. M. Impaired eye movements in presymptomatic spinocerebellar ataxia type 6. Arch. Neurol. 65, 530\u2013536 (2008).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol201479_CR194","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","volume":"10","author":"SJ Tabrizi","year":"2011","unstructured":"Tabrizi, S. J. et al. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol. 10, 31\u201342 (2011).","journal-title":"Lancet Neurol."},{"key":"BFnrneurol201479_CR195","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mus.20301","volume":"32","author":"L Machuca-Tzili","year":"2005","unstructured":"Machuca-Tzili, L., Brook, D. & Hilton-Jones, D. Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve 32, 1\u201318 (2005).","journal-title":"Muscle Nerve"},{"key":"BFnrneurol201479_CR196","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.ophtha.2011.02.027","volume":"118","author":"P Barboni","year":"2011","unstructured":"Barboni, P. et al. Retinal nerve fiber layer thickness in dominant optic atrophy: Measurements by optical coherence tomography and correlation with age. Ophthalmology 118, 2076\u20132080 (2011).","journal-title":"Ophthalmology"},{"key":"BFnrneurol201479_CR197","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ophtha.2004.06.034","volume":"112","author":"P Barboni","year":"2005","unstructured":"Barboni, P. et al. Retinal nerve fiber layer evaluation by optical coherence tomography in Leber's hereditary optic neuropathy. Ophthalmology 112, 120\u2013126 (2005).","journal-title":"Ophthalmology"},{"key":"BFnrneurol201479_CR198","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.bbabio.2009.02.024","volume":"1787","author":"V Carelli","year":"2009","unstructured":"Carelli, V. et al. Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders. Biochim. Biophys. Acta 1787, 518\u2013528 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnrneurol201479_CR199","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/jmg.2007.054270","volume":"46","author":"P Yu-Wai-Man","year":"2009","unstructured":"Yu-Wai-Man, P., Griffiths, P. G., Hudson, G. & Chinnery, P. F. Inherited mitochondrial optic neuropathies. J. Med. Genet. 46, 145\u2013158 (2009).","journal-title":"J. Med. Genet."},{"key":"BFnrneurol201479_CR200","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1056\/NEJM198905183202001","volume":"320","author":"CT Moraes","year":"1989","unstructured":"Moraes, C. T. et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns\u2013Sayre syndrome. N. Engl. J. Med. 320, 1293\u20131299 (1989).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol201479_CR201","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/brain\/awt321","volume":"137","author":"JP Grady","year":"2014","unstructured":"Grady, J. P. et al. Disease progression in patients with single, large-scale mitochondrial DNA deletions. Brain 137, 323\u2013334 (2014).","journal-title":"Brain"},{"key":"BFnrneurol201479_CR202","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1001\/archopht.1958.00940080296016","volume":"60","author":"TP Kearns","year":"1958","unstructured":"Kearns, T. P. & Sayre, G. P. Retinitis pigmentosa, external ophthalmophegia, and complete heart block: unusual syndrome with histologic study in one of two cases. AMA Arch. Ophthalmol. 60, 280\u2013289 (1958).","journal-title":"AMA Arch. Ophthalmol."},{"key":"BFnrneurol201479_CR203","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/ana.410390311","volume":"39","author":"S Rahman","year":"1996","unstructured":"Rahman, S. et al. Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann. Neurol. 39, 343\u2013351 (1996).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201479_CR204","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s100480100115","volume":"3","author":"K Huoponen","year":"2001","unstructured":"Huoponen, K. Leber hereditary optic neuropathy: clinical and molecular genetic findings. Neurogenetics 3, 119\u2013125 (2001).","journal-title":"Neurogenetics"},{"key":"BFnrneurol201479_CR205","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1600-0404.2006.00671.x","volume":"114","author":"J Finsterer","year":"2006","unstructured":"Finsterer, J. Central nervous system manifestations of mitochondrial disorders. Acta Neurol. Scand. 114, 217\u2013238 (2006).","journal-title":"Acta Neurol. Scand."},{"key":"BFnrneurol201479_CR206","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0387-7604(02)00220-6","volume":"25","author":"M Tsuji","year":"2003","unstructured":"Tsuji, M. et al. Leigh syndrome associated with West syndrome. Brain Dev. 25, 245\u2013250 (2003).","journal-title":"Brain Dev."},{"key":"BFnrneurol201479_CR207","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.410400107","volume":"40","author":"AA Morris","year":"1996","unstructured":"Morris, A. A. et al. Deficiency of respiratory chain complex I is a common cause of Leigh disease. Ann. Neurol. 40, 25\u201330 (1996).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201479_CR208","first-page":"428","volume":"46","author":"IJ Holt","year":"1990","unstructured":"Holt, I. J., Harding, A. E., Petty, R. K. & Morgan-Hughes, J. A. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am. J. Hum. Genet. 46, 428\u2013433 (1990).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneurol201479_CR209","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1212\/WNL.49.6.1714","volume":"49","author":"E Sembrano","year":"1997","unstructured":"Sembrano, E., Barthlen, G. M., Wallace, S. & Lamm, C. Polysomnographic findings in a patient with the mitochondrial encephalomyopathy NARP. Neurology 49, 1714\u20131717 (1997).","journal-title":"Neurology"},{"key":"BFnrneurol201479_CR210","first-page":"479","volume-title":"Handbook of Muscle Disease","author":"M Hirano","year":"1996","unstructured":"Hirano, M. & DiMauro, S. Clinical features of mitochondrial myopathies and encephalomyopathies. In Handbook of Muscle Disease (ed. Lane, R. J.) 479\u2013504 (Marcel Dekker, Inc., 1996)."},{"key":"BFnrneurol201479_CR211","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/088307389400900102","volume":"9","author":"M Hirano","year":"1994","unstructured":"Hirano, M. & Pavlakis, S. G. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J. Child Neurol. 9, 4\u201313 (1994).","journal-title":"J. Child Neurol."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2014.79.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2014.79","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2014.79.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T20:01:00Z","timestamp":1716753660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2014.79"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,20]]},"references-count":211,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["BFnrneurol201479"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2014.79","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,20]]},"assertion":[{"value":"20 May 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.V.D.-M. has received research grants from Alcon Laboratories, Allergan Limited and the Eye Institute (Auckland, New Zealand). H.M.K and R.H.R. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}